Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
ConditionMyopia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-45
SponsorVance Thompson Vision
About this trial
Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Eligibility criteria
Qualifiers
Subjects ages 21 to 45 years old.
Stable refractive error for at least one year (≤ 0.50 D change in refraction) or stability as determined by the Investigator.
Myopia or myopia with astigmatism with spherical equivalent ranging from -3.00 D to ≤ -8.00 D (in the spectacle plane) and cylinder in the range of 0.00 D to 4.00 D (in the spectacle plane).
Corrected distance visual acuity (CDVA) of 20/20 or better in each eye.
Disqualifiers
1. Pregnant or nursing women, or those who plan to become pregnant over the course of this clinical study or has another condition with associated fluctuation of hormones that could lead to refractive changes.
Pigment dispersion,
History or clinical signs of iritis/uveitis,
History of previous ocular surgery,
Trial design
Treatments tested in this trial
- Laser-assisted in Situ Keratomileusis
- Implantable Collamer Lens placement
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov